{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:51:35Z","timestamp":1776228695204,"version":"3.50.1"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This practice point applies to children and adolescents presenting to the emergency department with acute migraine. Current recommendations on management from relevant studies are summarized with the goal of decreasing practice variation among providers and preventing potential harm to patients. The first-line option for treatment of acute migraine attacks is metoclopramide, and potential second-line options include occipital nerve blocks and intra-nasal lidocaine. Opioids should not be used to treat migraine.<\/jats:p>","DOI":"10.1093\/pch\/pxaf139","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:53:13Z","timestamp":1766062393000},"page":"275-280","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological management of acute migraine attacks in children and adolescents presenting to the emergency department"],"prefix":"10.1093","volume":"31","author":[{"given":"Sarah","family":"Rogers","sequence":"first","affiliation":[{"name":"Canadian Paediatric Society, Acute Care Committee , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena L","family":"Orr","sequence":"additional","affiliation":[{"name":"Canadian Paediatric Society, Acute Care Committee , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Parisien","sequence":"additional","affiliation":[{"name":"Canadian Paediatric Society, Acute Care Committee , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel","family":"Chauvin-Kimoff","sequence":"additional","affiliation":[{"name":"Canadian Paediatric Society, Acute Care Committee , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"1","key":"2026041423571300400_pxaf139-B1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/spen.2001.23331","article-title":"Headache in the pediatric emergency department","volume":"8","author":"Lewis","year":"2001","journal-title":"Semin Pediatr Neurol"},{"key":"2026041423571300400_pxaf139-B2","doi-asserted-by":"crossref","DOI":"10.1017\/9781316819388","volume-title":"Emergency Headache: Diagnosis and Management","author":"Orr","year":"2017"},{"key":"2026041423571300400_pxaf139-B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pediatrneurol.2018.07.015","article-title":"A modern epidemic: Increasing pediatric emergency department visits and admissions for headache","volume":"89","author":"Perry","year":"2018","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2026041423571300400_pxaf139-B4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1017\/cjn.2016.402","article-title":"Migraine and mental health in a population-based sample of adolescents","volume":"44","author":"Orr","year":"2017","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"2026041423571300400_pxaf139-B5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1469-8749.2010.03793.x","article-title":"Prevalence of headache and migraine in children and adolescents: A systematic review of population-based studies","volume":"52","author":"Abu-Arafeh","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"10159","key":"2026041423571300400_pxaf139-B6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"2026041423571300400_pxaf139-B7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1468-2982.2008.01666.x","article-title":"Cumulative lifetime migraine incidence in women and men","volume":"28","author":"Stewart","year":"2008","journal-title":"Cephalalgia"},{"issue":"1","key":"2026041423571300400_pxaf139-B8","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1542\/peds.2009-2337","article-title":"Treatment of children with migraine in emergency departments: National practice variation study","volume":"126","author":"Richer","year":"2010","journal-title":"Pediatrics"},{"issue":"8","key":"2026041423571300400_pxaf139-B9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1177\/0883073817702025","article-title":"Disability, quality of life, and pain coping in pediatric migraine: An observational study","volume":"32","author":"Orr","year":"2017","journal-title":"J Child Neurol"},{"issue":"18","key":"2026041423571300400_pxaf139-B10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1212\/WNL.0b013e318271f812","article-title":"Migraine and migraine subtypes in preadolescent children: Association with school performance","volume":"79","author":"Arruda","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"2026041423571300400_pxaf139-B11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1468-2982.2008.01583.x","article-title":"Friendships and social interactions of school-aged children with migraine","volume":"28","author":"Vannatta","year":"2008","journal-title":"Cephalalgia"},{"issue":"1","key":"2026041423571300400_pxaf139-B12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/head.12746","article-title":"Acute treatment therapies for pediatric migraine: A qualitative systematic review","volume":"56","author":"Patniyot","year":"2016","journal-title":"Headache"},{"issue":"1","key":"2026041423571300400_pxaf139-B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"2","key":"2026041423571300400_pxaf139-B14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0196-0644(05)80201-x","article-title":"The efficacy of metoclopramide in the treatment of migraine headache","volume":"22","author":"Ellis","year":"1993","journal-title":"Ann Emerg Med"},{"issue":"6","key":"2026041423571300400_pxaf139-B15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/head.14307","article-title":"A randomized trial of ketorolac and metoclopramide for migraine in the emergency department","volume":"62","author":"Richer","year":"2022","journal-title":"Headache"},{"issue":"2","key":"2026041423571300400_pxaf139-B16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/s0196-0644(03)00716-9","article-title":"Treatment of pediatric migraine headaches: A randomized, double-blind trial of prochlorperazine versus ketorolac","volume":"43","author":"Brousseau","year":"2004","journal-title":"Ann Emerg Med"},{"issue":"4","key":"2026041423571300400_pxaf139-B17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/acem.14422","article-title":"Intranasal ketorolac versus intravenous ketorolac for treatment of migraine headaches in children: A randomized clinical trial","volume":"29","author":"Tsze","year":"2022","journal-title":"Acad Emerg Med"},{"issue":"4","key":"2026041423571300400_pxaf139-B18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajem.2015.12.080","article-title":"Intravenous fluids for migraine: A post hoc analysis of clinical trial data","volume":"34","author":"Balbin","year":"2016","journal-title":"Am J Emerg Med"},{"issue":"9","key":"2026041423571300400_pxaf139-B19","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/head.12443","article-title":"Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine","volume":"54","author":"Richer","year":"2014","journal-title":"Headache"},{"issue":"1","key":"2026041423571300400_pxaf139-B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1212\/wnl.48.1.103","article-title":"Ibuprofen or Acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study","volume":"48","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Neurology"},{"issue":"8","key":"2026041423571300400_pxaf139-B21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","article-title":"Children's ibuprofen suspension for the acute treatment of pediatric migraine","volume":"42","author":"Lewis","year":"2002","journal-title":"Headache"},{"issue":"16","key":"2026041423571300400_pxaf139-B22","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1517\/14656566.2012.730041","article-title":"Sumatriptan succinate: Pharmacokinetics of different formulations in clinical practice","volume":"13","author":"Lionetto","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"9294","key":"2026041423571300400_pxaf139-B23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: A meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"2026041423571300400_pxaf139-B24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1517\/14656566.2014.858120","article-title":"Sumatriptan in clinical practice: Effectiveness in migraine and the problem of psychiatric comorbidity","volume":"15","author":"Napoletano","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"2026041423571300400_pxaf139-B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-016-0717-7","article-title":"Randomized, double-blind, crossover study comparing DFN-11 injection (3mg subcutaneous sumatriptan) with 6mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine","volume":"18","author":"Cady","year":"2017","journal-title":"J Headache Pain"},{"issue":"4","key":"2026041423571300400_pxaf139-B26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1526-4610.2007.00756.x","article-title":"Effect of pain intensity and time to administration on responsiveness to almotriptan: Results from AXERT 12.5mg time versus intensity migraine study (AIMS)","volume":"47","author":"Freitag","year":"2007","journal-title":"Headache"},{"issue":"4","key":"2026041423571300400_pxaf139-B27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1468-2982.2008.01546.x","article-title":"Early vs. non-early intervention in acute migraine\u2014\u2018Act when Mild (AwM)\u2019. A double-blind, placebo-controlled trial of almotriptan","volume":"28","author":"Goadsby","year":"2008","journal-title":"Cephalalgia"},{"issue":"6","key":"2026041423571300400_pxaf139-B28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/pch\/pxac054","article-title":"A randomized controlled pilot study of intranasal lidocaine in acute management of paediatric migraine and migraine-like headache","volume":"27","author":"Maki","year":"2022","journal-title":"Paediatr Child Health"},{"issue":"10","key":"2026041423571300400_pxaf139-B29","doi-asserted-by":"publisher","first-page":"e0224285","DOI":"10.1371\/journal.pone.0224285","article-title":"Intranasal lidocaine for acute migraine: A meta-analysis of randomized controlled trials","volume":"14","author":"Chi","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"2026041423571300400_pxaf139-B30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/ane.13325","article-title":"Intravenous sodium valproate for acute migraine in the emergency department: A meta-analysis","volume":"142","author":"Wang","year":"2020","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"2026041423571300400_pxaf139-B31","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1526-4610.2005.05158.x","article-title":"Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine","volume":"45","author":"Reiter","year":"2005","journal-title":"Headache"},{"issue":"4","key":"2026041423571300400_pxaf139-B32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jemermed.2015.02.024","article-title":"Intravenous sodium valproate for acute pediatric headache","volume":"49","author":"Sheridan","year":"2015","journal-title":"J Emerg Med"},{"issue":"4","key":"2026041423571300400_pxaf139-B33","doi-asserted-by":"publisher","first-page":"e200170","DOI":"10.1212\/CPJ.0000000000200170","article-title":"Efficacy of IV valproic acid and oral valproic acid tapers for the treatment of pediatric headaches in the emergency department","volume":"13","author":"Rosenthal","year":"2023","journal-title":"Neurol Clin Pract"},{"issue":"10","key":"2026041423571300400_pxaf139-B34","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/head.13648","article-title":"Intravenous magnesium sulfate to treat acute headaches in the emergency department: A systematic review","volume":"59","author":"Miller","year":"2019","journal-title":"Headache"},{"issue":"6","key":"2026041423571300400_pxaf139-B35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1067\/mem.2001.119424","article-title":"Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache","volume":"38","author":"Corbo","year":"2001","journal-title":"Ann Emerg Med"},{"issue":"2","key":"2026041423571300400_pxaf139-B36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jemermed.2013.08.049","article-title":"Intravenous magnesium as acute treatment for headaches: A pediatric case series","volume":"46","author":"Gertsch","year":"2014","journal-title":"J Emerg Med"},{"issue":"1","key":"2026041423571300400_pxaf139-B37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/pm\/pnab236","article-title":"Percutaneous interventional strategies for migraine prevention: A systematic review and practice guideline","volume":"23","author":"Barad","year":"2022","journal-title":"Pain Med"},{"issue":"17_supplement_1","key":"2026041423571300400_pxaf139-B38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000205849","article-title":"Randomized controlled trial of lidocaine occipital nerve blocks to treat status migrainosus in children\/adolescents (S22.009)","volume":"102","author":"Szperka","year":"2024","journal-title":"Neurology"},{"issue":"9","key":"2026041423571300400_pxaf139-B39","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.ajem.2014.07.001","article-title":"Trends in opioid analgesic use for headaches in US emergency departments","volume":"32","author":"Mazer-Amirshahi","year":"2014","journal-title":"Am J Emerg Med"},{"issue":"23","key":"2026041423571300400_pxaf139-B40","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.2021.7939","article-title":"Acute treatments for episodic migraine in adults: A systematic review and meta-analysis","volume":"325","author":"VanderPluym","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"2026041423571300400_pxaf139-B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1542\/hpeds.2020-0007","article-title":"Opioid use to treat migraine headaches in hospitalized children and adolescents","volume":"10","author":"Masonbrink","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"1","key":"2026041423571300400_pxaf139-B42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jadohealth.2013.12.014","article-title":"Opioid use among adolescent patients treated for headache","volume":"55","author":"DeVries","year":"2014","journal-title":"J Adolesc Health"},{"key":"2026041423571300400_pxaf139-B43","author":"Choosing Wisely Canada"},{"key":"2026041423571300400_pxaf139-B44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2019.06.011","article-title":"Ondansetron for acute migraine in the pediatric emergency department","volume":"103","author":"Talai","year":"2020","journal-title":"Pediatr Neurol"},{"issue":"11","key":"2026041423571300400_pxaf139-B45","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1177\/0333102414566200","article-title":"The place of corticosteroids in migraine attack management: A 65-year systematic review with pooled analysis and critical appraisal","volume":"35","author":"Woldeamanuel","year":"2015","journal-title":"Cephalalgia"},{"issue":"7657","key":"2026041423571300400_pxaf139-B46","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/bmj.39566.806725.BE","article-title":"Parenteral dexamethasone for acute severe migraine headache: Meta-analysis of randomised controlled trials for preventing recurrence","volume":"336","author":"Colman","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"2026041423571300400_pxaf139-B47","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1553-2712.2008.00283.x","article-title":"Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature","volume":"15","author":"Singh","year":"2008","journal-title":"Acad Emerg Med"},{"issue":"2","key":"2026041423571300400_pxaf139-B48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/emermed-2012-202190.3","article-title":"Towards evidence-based emergency medicine: Best BETs from the Manchester Royal Infirmary. BET 2: Dexamethasone for reduction of migraine recurrence","volume":"30","author":"Neill","year":"2013","journal-title":"Emerg Med J"},{"issue":"8","key":"2026041423571300400_pxaf139-B49","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/ene.12155","article-title":"Steroids for preventing recurrence of acute severe migraine headaches: A meta-analysis","volume":"20","author":"Huang","year":"2013","journal-title":"Eur J Neurol"},{"issue":"10","key":"2026041423571300400_pxaf139-B50","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/head.12654","article-title":"Factors influencing migraine recurrence after infusion and inpatient migraine treatment in children and adolescents","volume":"55","author":"Cobb-Pitstick","year":"2015","journal-title":"Headache"},{"issue":"17","key":"2026041423571300400_pxaf139-B51","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","article-title":"Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults; report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Holland","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"2026041423571300400_pxaf139-B52","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1177\/0883073808318053","article-title":"High-dose riboflavin for migraine prophylaxis in children: A double-blind, randomized, placebo-controlled trial","volume":"23","author":"MacLennan","year":"2008","journal-title":"J Child Neurol"},{"issue":"12","key":"2026041423571300400_pxaf139-B53","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1177\/0333102410365106","article-title":"Medium-dose riboflavin as a prophylactic agent in children with migraine: A preliminary placebo-controlled, randomised, double-blind, cross-over trial","volume":"30","author":"Bruijn","year":"2010","journal-title":"Cephalalgia"},{"issue":"5","key":"2026041423571300400_pxaf139-B54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10194-009-0142-2","article-title":"Riboflavin prophylaxis in pediatric and adolescent migraine","volume":"10","author":"Cond\u00f2","year":"2009","journal-title":"J Headache Pain"},{"issue":"6","key":"2026041423571300400_pxaf139-B55","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1526-4610.2003.03102.x","article-title":"Oral magnesium oxide prophylaxis of frequent migrainous headache in children: A randomized, double-blind, placebo-controlled trial","volume":"43","author":"Wang","year":"2003","journal-title":"Headache"},{"issue":"2","key":"2026041423571300400_pxaf139-B56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/head.12162","article-title":"Effects of Acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium","volume":"54","author":"Gallelli","year":"2014","journal-title":"Headache"},{"issue":"2","key":"2026041423571300400_pxaf139-B57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1468-2982.2002.00335.x","article-title":"Open label trial of coenzyme Q10 as a migraine preventive","volume":"22","author":"Rozen","year":"2002","journal-title":"Cephalalgia"},{"issue":"4","key":"2026041423571300400_pxaf139-B58","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","article-title":"Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial","volume":"64","author":"S\u00e1ndor","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"2026041423571300400_pxaf139-B59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1526-4610.2007.00652.x","article-title":"Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine","volume":"47","author":"Hershey","year":"2007","journal-title":"Headache"},{"issue":"8","key":"2026041423571300400_pxaf139-B60","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1177\/0333102411406755","article-title":"A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine","volume":"31","author":"Slater","year":"2011","journal-title":"Cephalalgia"}],"container-title":["Paediatrics &amp; Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pch\/article-pdf\/31\/3\/275\/67280636\/pxaf139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pch\/article-pdf\/31\/3\/275\/67280636\/pxaf139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:57:21Z","timestamp":1776225441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pch\/article\/31\/3\/275\/8512255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/pch\/pxaf139","relation":{},"ISSN":["1205-7088","1918-1485"],"issn-type":[{"value":"1205-7088","type":"print"},{"value":"1918-1485","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,9]]}}}